[Edaily Reporter Shin Ha-yeon] As U.S. President Donald Trump announced that peace negotiations with Iran have reached the final stage of document coordination, construction stocks are rallying across the board on the domestic stock market. According to MP Doctor as of 9:11 a.m. on the 12th, #Daewoo Construction is trading at 23,250 won, up 13.69% from the previous trading day. At the same time, #Hyundai Construction (9.54%), #GS Construction (9.16%), #Samsung C&T (8.29%), #DL E&C (6.70%), and #IPARK Hyundai Industrial Development (3.67%) are all rising in unison. This is interpreted as buying interest flooding into construction-related stocks as the potential to benefit from post-war reconstruction demand comes into focus. On the 11th (local time), President Trump presided over a signing ceremony at the White House for a proclamation unrelated to the Iran deal, stating, “We have just reached a great settlement regarding the war with Iran,” and added, “Only the final coordination of the document remains.” He added, “It will be finalized within the next few days, and the signing ceremony will likely take place in Europe.” Confirming the timing of the signing ceremony as “probably this weekend,” he said, “I won’t be able to attend, but Vice President JD Vance will be there.” He also said, “The Strait of Hormuz will open as soon as the agreement is signed,” adding, “It might be as early as Saturday.” He further stated that the U.S. naval blockade against Iran would be lifted simultaneously with the signing. However, Iran’s state-run IRNA news agency reported that Esmail Baghai, a spokesperson for the Iranian Foreign Ministry, said on the same day that nothing had been finalized regarding the signing of the agreement and that all reports regarding the time and place of the signing were merely “speculation.”
The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…